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Inspiratory pressure-generating capacity is preserved during ventilatory and non-ventilatory 
behaviours in young dystrophic mdx mice despite profound diaphragm muscle weakness  
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*Corresponding author: 
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Short title: Respiratory compensation in young mdx mice.  
Abbreviations: ½ RT, half-relaxation time; ANOVA, analysis of variance; CSA, cross-sectional area; CT, 
contraction time; DMD, Duchenne muscular dystrophy; EIC, external intercostal; EMG, 
electromyogram; ETCO2, end-tidal carbon dioxide; fR, respiratory frequency; FiO2, fractional inspired 
oxygen concentration; Lo, optimum length; PIF, peak inspiratory flow; PEF, peak expiratory flow; Pt, 
twitch force; Po, tetanic force; Smax, maximum total shortening; SpO2, peripheral capillary oxygen 
saturation; T3, third intercostal space; VE, minute ventilation; Vmax, maximum shortening velocity; 
VT, tidal volume; VT/Ti, mean inspiratory flow; WT, wild-type. 
Key points  
 Respiratory muscle weakness is a major feature of Duchenne muscular dystrophy (DMD), yet 
little is known about the neural control of the respiratory muscles in DMD and animal 
models of dystrophic disease. 
 Substantial diaphragm muscle weakness is apparent in young (8-week-old) mdx mice, but 
ventilatory capacity in response to maximum chemostimulation in conscious mice is 
preserved.  
 Peak volume- and flow-related measures during chemoactivation are equivalent in 
anaesthetized, vagotomized wild-type and mdx mice. 
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 Diaphragm and T3 external intercostal EMG activities are lower during protracted sustained 
airway occlusion in mdx compared with wild-type mice. Yet, peak inspiratory pressure 
generation is remarkably well preserved. 
 Despite profound diaphragm weakness and lower muscle activation during maximum non-
ventilatory efforts, inspiratory pressure-generating capacity is preserved in young adult mdx 
mice, revealing compensation in support of respiratory system performance that is 
adequate, at least early in dystrophic disease.  
Abstract 
Diaphragm dysfunction is recognized in the mdx mouse model of muscular dystrophy, however 
there is a paucity of information concerning the neural control of dystrophic respiratory muscles. In 
young adult (8 weeks of age) male wild-type and mdx mice, we assessed ventilatory capacity, neural 
activation of the diaphragm and external intercostal (EIC) muscles and inspiratory pressure-
generating capacity during ventilatory and non-ventilatory behaviours. We hypothesized that 
respiratory muscle weakness is associated with impaired peak inspiratory pressure-generating 
capacity in mdx mice. Ventilatory responsiveness to hypercapnic hypoxia was determined in 
conscious mice by whole-body plethysmography. Diaphragm isometric and isotonic contractile 
properties were determined ex vivo. In anaesthetized mice, thoracic oesophageal pressure, and 
diaphragm and EIC electromyogram (EMG) activities were recorded during baseline conditions and 
sustained tracheal occlusion for 30-40s. Despite substantial diaphragm weakness, mdx mice retain 
the capacity to enhance ventilation during hypercapnic hypoxia. Peak volume- and flow-related 
measures were also maintained in anaesthetized, vagotomized mdx mice. Peak inspiratory pressure 
was remarkably well preserved during chemoactivated breathing, augmented breaths, and maximal 
sustained efforts during airway obstruction in mdx mice. Diaphragm and EIC EMG activities were 
lower during airway obstruction in mdx compared with wild-type mice. We conclude that ventilatory 
capacity is preserved in young mdx mice. Despite profound respiratory muscle weakness and lower 
diaphragm and EIC EMG activities during high demand in mdx mice, peak inspiratory pressure is 
preserved, revealing adequate compensation in support of respiratory system performance, at least 
early in dystrophic disease. We suggest that a progressive loss of compensation during advancing 
disease, combined with diaphragm dysfunction, underpins the development of respiratory system 
morbidity in dystrophic diseases.  
Keywords: DMD; mdx; breathing; oesophageal pressure; EMG; diaphragm; intercostal   
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1. Introduction 
Dystrophin is a structural protein expressed in muscle and the central nervous system (Lidov, 1996; 
Muntoni et al., 2003). Duchenne muscular dystrophy (DMD) is a severe neuromuscular disease 
caused by dystrophin deficiency (Hoffman et al., 1987; Ervasti, 2007). Respiratory muscle 
dysfunction is described in DMD patients (De Bruin et al., 1997; Beck et al., 2006) with deleterious 
consequences for respiratory system performance (Mayer et al., 2015). Loss of ambulation and 
cardio-respiratory failure are cardinal features of DMD (Yiu & Kornberg, 2008). Life expectancy for 
DMD boys is severely curtailed and there is currently no cure for the devastating disease. 
Substantial diaphragm muscle weakness is reported in patients and animal models of DMD 
(Stedman et al., 1991; Khirani et al., 2014). However, there remains an incomplete understanding of 
the neural control of breathing in DMD and dystrophic animal models, where further deficits or 
compensation may arise with implications for respiratory performance (Burns et al., 2017c). A 
thorough understanding of the consequences of dystrophin deficiency for the control of breathing is 
essential in the consideration of disease progression and therapeutic strategies to combat 
respiratory insufficiency in human dystrophinopathies. 
Dystrophin is ordinarily expressed in neurons (Lidov, 1996). In the mdx mouse model of DMD, 
studies indicate reduced number of cortico-spinal neurons (Sbriccoli et al., 1995), damage to motor 
pathways (Carretta et al., 2001), loss of neuronal projections (Pinto et al., 2008), GABAergic 
dysfunction (Sekiguchi et al., 2009; Vaillend & Chaussenot, 2017) and cognitive deficits (Chaussenot 
et al., 2015). It is unclear if dystrophin deficiency affects nervous system control of breathing. A 
comprehensive understanding of the motor control of the dystrophin deficient respiratory 
musculature is lacking. It is essential to determine if dystrophin deficiency is deleterious to the 
motor control of breathing and respiratory-related behaviours, or if there is intrinsic compensation 
within the neural control circuits, facilitating performance. Recently, we described evidence of 
enhanced motor drive to the mdx diaphragm during chemoactivation of breathing (Burns et al., 
2017c), suggesting intrinsic compensation in the neural control of ventilation in dystrophin deficient 
mice. Our studies have revealed a retained capacity to increase ventilation in response to modest 
chemostimulation in young mdx mice (Burns et al., 2017c). However, the extent to which dystrophin 
deficiency affects inspiratory pressure-generating capacity across a range of ventilatory and non-
ventilatory behaviours (Mantilla et al., 2010; Seven et al., 2014) is unclear, but important to 
establish. Clearly, aberrant neural control of breathing could serve to exacerbate respiratory 
morbidity in DMD, compounding mechanical constraints arising from respiratory muscle 
dysfunction.  
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Our principal objective was to perform an assessment of respiratory system performance during 
ventilatory and non-ventilatory behaviours in the mdx mouse model of DMD. We assessed 
ventilatory capacity during hypercapnic hypoxic breathing in conscious mice. In anaesthetized mice, 
we determined inspiratory pressure-generating capacity and diaphragm and external intercostal 
(EIC) electromyogram (EMG) activities during ventilatory (chemoactivation and augmented breaths) 
and non-ventilatory (airway obstruction) behaviours. We hypothesized that respiratory muscle 
weakness is associated with impaired peak inspiratory pressure-generating capacity in mdx mice.  
2. Methods 
2.1 Ethical approval 
Procedures on live animals were performed under licence in accordance with Irish and European law 
following approval by University College Cork animal research ethics committee (AEEC no. 
2013/035). Experiments were carried out in accordance with guidelines laid down by University 
College Cork Animal Welfare Body, and conform to the principles and regulations described by 
Grundy (2015). 
2.2 Experimental animals  
Male wild-type (C57BL/10ScSnJ; n=28) and mdx (C57BL/10ScSn-Dmdmdx/J; n=26) mice were 
purchased from the Jackson Laboratory (Bar Harbor, ME, USA) and studied at eight weeks of age. 
Animals were housed in individually ventilated cages in our institution’s animal housing facility. All 
animals were housed in temperature- and humidity-controlled rooms, operating on a 12 h light:12 h 
dark cycle with food and water available ad libitum. 
2.3 Whole-body plethysmography 
Whole-body plethysmography was used to assess respiratory flow in unrestrained, unanaesthetized 
mice. Mice were introduced into plethysmograph chambers (Model PLY4211; volume 600ml, Buxco 
Research Systems, Wilmington, NC, USA) and allowed 60-90 min to acclimate to the chamber 
environment. Following exploration and grooming behaviours, mice settled and were studied during 
quiet rest. Recordings were typically performed contemporaneously in a wild-type and mdx mouse 
using a pair of plethysmograph chambers. 
Experimental protocol: Following acclimation and a settling period, a 20-min baseline recording was 
performed in normoxia. This was followed by a graded hypercapnic challenge wherein animals were 
challenged with increasing levels of inspired carbon dioxide: FiCO2 = 0.02, 0.04 and 0.06 (FiO2 = 0.21) 
consecutively for 5 min each. This was immediately followed by maximal chemoreceptor stimulation 
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with hypercapnic hypoxia (FiO2 = 0.10/ FiCO2 = 0.06) for 5 min, to examine ventilatory capacity in 
wild-type (n = 9) and mdx (n = 7) mice. Mice were subsequently euthanized by urethane overdose.  
Data analysis: Ventilation during hypercapnia and hypercapnic hypoxia was determined during 
steady-state conditions in the 5th minute of exposure and compared with the preceding baseline 
normoxic period. Tidal volume (VT), minute ventilation (VE) and mean inspiratory flow (VT.Ti
-1) were 
normalized for body mass (g). 
2.4 Diaphragm EMG and oesophageal pressure recordings 
Anaesthesia was induced with 5% isoflurane in 60% O2 (balance N2) followed by urethane (1.7g.kg
-1 
i.p.). Wild-type (n = 9) and mdx (n = 9) mice were then placed in the supine position, gradually 
weaned from the isoflurane and body temperature was maintained at 37oC via a rectal probe and 
thermostatically-controlled heating blanket (Harvard Apparatus, Holliston, MA, USA). Supplemental 
anaesthetic was administered if necessary to maintain an adequate surgical plane of anaesthesia, 
which was by assessment of pedal withdrawal reflex to noxious pinch. A pulse oximeter clip 
(MouseOxTM, Starr Life Sciences Corporation, Oakmount, PA, USA) was placed on a shaved thigh of 
each mouse for the measurement of peripheral capillary O2 saturation (SpO2). A mid-cervical 
tracheotomy was performed. All animals were maintained with a bias flow of supplemental O2 (FiO2 
= 0.60) under baseline conditions. End-tidal carbon dioxide (ETCO2) was measured using a 
MicroCapStar (CWE, Ardmore, PA). To estimate intra-pleural sub-atmospheric pressure generated by 
the respiratory musculature during inspiration, we measured oesophageal pressure using a pressure-
tip catheter (Mikro-Tip, Millar Inc., Houston, TX, USA), which was positioned in the thoracic 
oesophagus through the mouth. During inspiratory activity, oesophageal recordings displayed phasic 
sub-atmospheric pressure swings. Concentric needle electrodes (26G; Natus Manufacturing Ltd, 
Ireland) were inserted into the costal diaphragm for the continuous measurement of diaphragm 
EMG activity, which was amplified (x5,000), filtered (500Hz low cut-off to 5,000Hz high cut-off) and 
integrated (50ms time constant; Neurolog system, Digitimer Ltd, UK). All signals were passed 
through an analogue-to-digital converter (Powerlab r8/30; ADInstruments, Colorado Springs, CO, 
USA) and were acquired using LabChart 7 (ADInstruments).  
Experimental protocol: Following instrumentation, animals were allowed at least 10 min to stabilize 
before baseline parameters were measured for a period of 10 min. Next, animals were challenged 
with hypercapnic hypoxia (FiO2 = 0.15 & FiCO2 = 0.05; 1 min) to examine the effects of 
chemostimulation on diaphragm EMG activity and oesophageal inspiratory pressure generation. 
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Following the experimental protocol, mice were euthanized by decapitation. Diaphragm muscle was 
excised for ex vivo functional analysis (section 2.6).  
Data analysis: The amplitudes of integrated inspiratory diaphragm EMG activity and peak inspiratory 
sub-atmospheric oesophageal pressure were analyzed and averaged under steady-state basal 
conditions and averaged for the final 15 breaths (maximal response) of the hypercapnic hypoxia 
challenge. Oesophageal pressure is reported in absolute units (cmH2O). EMG data are reported in 
arbitrary units (A.U.). In one wild-type and three mdx mice, responses to chemostimulation were 
characterized by tachypnoea and a reduction in EMG amplitude. Since, our aim was to examine the 
magnitude of the increase in EMG amplitude (motor recruitment) of the diaphragm during maximal 
chemoreceptor stimulation with hypercapnic hypoxia we determined a priori that trials 
characterized by frequency-only responses to gas challenge in wild-type and mdx mice would be 
excluded from group analysis, consistent with our approach in a recent study (Burns et al., 2017c). 
Spontaneous augmented breaths (sighs) observed during baseline conditions were analyzed and 
compared with the average of the preceding five breaths. Augmented breaths were classified as 
breaths with more than double the baseline EMG amplitude (Mantilla et al., 2011; Seven et al., 
2014). For two wild-type mice, no breath met this criterion during the recording period. 
2.5 Diaphragm and EIC EMG and oesophageal pressure recordings 
In separate studies, wild-type (n=10) and mdx (n=10) mice were anaesthetized and tracheotomized 
as described above (section 2.4). Oesophageal pressure and costal diaphragm EMG activity were 
recorded. In addition, a concentric needle electrode was inserted in the third intercostal space (T3) 
for the measurement of EIC EMG, which was amplified (x5,000), filtered (500Hz low cut-off to 
5,000Hz high cut-off) and integrated (50ms time constant; Neurolog system, Digitimer Ltd, UK). All 
signals were passed through an analogue-to-digital converter and were acquired using LabChart 7.  
Experimental protocol: Following instrumentation, animals were allowed at least 10 min to stabilize 
before baseline parameters were measured for a period of 10 min. Next, a pneumotachometer was 
connected to the tracheal cannula to record respiratory airflow for a period of 1-2 min. The 
pneumotachometer and ETCO2 were disconnected and following a baseline period, animals were 
challenged with sustained tracheal occlusion for 30-40s until a plateau was observed in the 
inspiratory pressure recordings during sustained maximum non-ventilatory efforts. Following 
recovery, animals were instrumented for the measurement of ETCO2 and tracheal airflow and the 
vagi were sectioned bilaterally at the cervical level. Respiratory parameters were recorded for 10 
min under steady-state conditions following vagotomy. Next, animals were challenged with 
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hypercapnic hypoxia (FiO2 = 0.15 & FiCO2 = 0.06; 3 min) to examine the effects of chemostimulation 
on diaphragm and EIC EMG activities and tracheal airflow. Following the experimental protocol, mice 
were euthanized by decapitation.  
Data analysis: The amplitudes of integrated inspiratory diaphragm and EIC EMG activities and peak 
inspiratory sub-atmospheric oesophageal pressure were analyzed and averaged under steady-state 
basal conditions and averaged for the 5 successive maximal sustained efforts (maximal response) of 
the airway occlusion challenge. During baseline breathing and chemoactivation, VT was derived from 
tracheal airflow measurements. Spontaneous peak breaths observed during chemoactivation in 
vagotomized mice, notably greater in amplitude than neighbouring breaths, were analyzed and 
compared with the preceding baseline period to provide a measure of maximum ventilatory effort. 
Spontaneous peak breaths during hypercapnic hypoxia were observed in 5 wild-type and 5 mdx mice 
and were analyzed as a measure of peak ventilatory performance. 
2.6 Ex vivo diaphragm muscle function 
Diaphragm muscle was excised with a rib and central tendon attached. Muscle bundles with 
longitudinally arranged muscle fibres were prepared for functional assessment and suspended 
vertically between two platinum plate electrodes. The rib was attached to an immobile hook and the 
central tendon was attached to a dual-mode force transducer (Aurora Scientific Inc.; Aurora, ON, 
Canada) with non-elastic string. Diaphragm muscle preparations from wild-type (n = 8) and mdx (n = 
9) mice were studied in a water-jacketed tissue bath at 35oC containing Krebs solution (in mM: 120 
NaCl, 5 KCl, 2.5 Ca2+, 1.2 MgSO4, 1.2 NaH2PO4, 25 NaHCO3, 11.5 glucose) and D-tubocurarine (25 M) 
and were continuously aerated with carbogen (FiO2 = 0.95 & FiCO2 = 0.05). Muscle optimum length 
(Lo) was determined by adjusting the position of the force transducer, in turn adjusting the length of 
the muscle preparations, using a micro-positioner between intermittent twitch contractions (Burns 
& O'Halloran, 2016; Burns et al., 2017b). Lo was determined as the muscle length which revealed 
maximal isometric twitch force in response to single isometric twitch stimulation (supramaximal 
stimulation, 1ms duration). Preparations remained at Lo for the duration of the protocol. 
Experimental protocol: A single isometric twitch contraction was measured. Peak isometric twitch 
force (Pt), contraction time (CT) and half-relaxation time (½ RT) were determined. Peak isometric 
force at 100Hz (Po) was determined. The force-frequency relationship was examined by stimulating 
the muscle sequentially at 10, 20, 40, 60, 80, 100, 120, 140 and 160 Hz (300ms train duration). 
Contractions were interspersed by a 1 min interval. Next, an isotonic contraction was elicited in 
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preparations at 0% load to examine maximum unloaded muscle shortening and velocity of 
shortening (Burns & O'Halloran, 2016; Burns et al., 2017b). 
Data analysis: Muscle force was normalized for muscle cross-sectional area (CSA) and expressed as 
specific force (N cm-2). The CSA of each muscle bundle was determined by dividing muscle mass 
(weight in grams) by the product of muscle Lo (cm) and muscle density (assumed to be 1.06 g cm
-3). 
CT and ½ RT were measured as indices of isometric twitch kinetics. Total muscle shortening was 
determined as the maximum distance shortened during contraction. Total muscle shortening (Smax) 
was determined in absolute units (cm) and was normalized to Lo and expressed in L.Lo
-1. Shortening 
velocity was determined as the distance shortened during the initial 30 ms of shortening (Lewis et 
al., 2015; 2016). Shortening velocity (Vmax) was determined in absolute units (cm.s-1) and was 
normalized to Lo and expressed in Lo.s
-1. 
2.7 Statistical analysis  
Values are expressed as mean  SD or as box and whisker plots (median, 25-75 percentile, and 
scatter plot). Data were statistically compared using Prism 6.0 (Graphpad Software, San Diego, CA, 
USA). Data were tested for normal distribution and equal variances. Data sets which were normally 
distributed and of equivalent variance were statistically compared using unpaired two-tailed 
Student’s t test. Welch’s correction was applied in the case of unequal variance. Data which were 
not normally distributed were compared using Mann Whitney non-parametric tests. Data for 
diaphragm muscle force-frequency relationship, ventilatory responsiveness to chemostimulation in 
conscious mice, oesophageal pressure and EMG activities during obstruction, and flow, volume and 
EMG measures during peak breaths in vagotomized mice during chemoactivation were statistically 
compared by repeated measures two-way ANOVA with Bonferroni post hoc test. P < 0.05 was 
considered statistically significant in all tests.  
3. Results 
3.1 Diaphragm muscle contractile function ex vivo 
Figure 1 shows representative original recordings for wild-type (black) and mdx (grey) diaphragm 
twitch (A) and tetanic (B) contractions, force-frequency relationship (C) and maximal unloaded 
shortening (D). Twitch kinetics (CT and ½ RT) and isotonic contractile parameters (Smax and Vmax) 
are shown in Table 1. Twitch CT was significantly increased in mdx compared with wild-type 
diaphragm (P = 0.027; unpaired Student’s t test). Twitch ½ RT and isotonic contractile parameters 
were not significantly different between wild-type and mdx diaphragm preparations, with the 
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exception of absolute shortening and absolute velocity of shortening, which were significantly less in 
mdx compared with wild-type mice (Table 1). Diaphragm twitch (P = 0.0241; unpaired Student’s t 
test; Fig. 1E, Pt) and tetanic force (P < 0.0001; unpaired Student’s t test with Welch’s correction; Fig. 
1E, Po) were both significantly depressed in mdx compared with wild-type muscle. For the force-
frequency relationship, diaphragm specific force was significantly lower in mdx compared with wild-
type preparations (P = 0.0003 (genotype); repeated measures two-way ANOVA; Fig. 1F). Post hoc 
analysis confirmed significant force depression in mdx across a broad range of stimulation 
frequencies (60-160 Hz).  
3.2 Ventilatory responsiveness to hypercapnic hypoxia in conscious mice 
Figure 2A shows representative respiratory flow traces for wild-type and mdx mice during exposure 
to baseline air (FiO2 = 0.21) and hypercapnic hypoxia (FiO2 = 0.10 & FiCO2 = 0.06). Chemostimulation 
with graded hypercapnia and hypercapnic hypoxia resulted in a significant increase in fR (P < 0.0001 
(gas); repeated measures two-way ANOVA; Fig. 2B), VT (P < 0.0001; Fig. 2C), VE (P < 0.0001; Fig. 2D) 
and VT.Ti
-1 (P < 0.0001; Fig. 2E) both for wild-type and mdx mice, with no difference between the two 
groups.  
3.3 Oesophageal pressure and diaphragm EMG activity in anaesthetized mice 
Representative original recordings of oesophageal pressure and diaphragm EMG during baseline 
conditions (FiO2 = 0.60) and during a representative spontaneous augmented breath (shaded) are 
shown in Figure 3A. Table 2 shows baseline respiratory measurements in wild-type and mdx mice. 
Respiratory frequency was significantly higher in mdx compared with wild-type mice (P < 0.0001; 
unpaired Student’s t test; Table 2). There was no significant difference in SpO2 and ETCO2 between 
wild-type and mdx mice (Table 2).  
Peak inspiratory oesophageal pressure during baseline recordings was equivalent between wild-type 
and mdx mice (P = 0.2887; unpaired Student’s t test; Fig. 3B). Baseline diaphragm EMG activity was 
significantly lower in mdx (P = 0.025; unpaired Student’s t test with Welch’s correction; Fig. 3C) 
compared with wild-type mice. The peak inspiratory pressure generated during chemoactivation 
(FiO2 = 0.15 & FiCO2 = 0.05) was equivalent in wild-type and mdx mice, with a trend towards greater 
sub-atmospheric pressure generation in mdx mice (P = 0.0563; unpaired Student’s t test; Fig. 3B). 
Diaphragm EMG activity during chemoactivation was not different between wild-type and mdx mice 
(P = 0.0853; unpaired Student’s t test with Welch’s correction; Fig. 3C). Peak inspiratory oesophageal 
pressure during augmented breaths was greater in mdx compared with wild-type mice (P = 0.0013; 
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unpaired Student’s t test; Fig. 3B). Diaphragm EMG during augmented breaths was equivalent 
between wild-type and mdx mice (P = 0.2031; unpaired Student’s t test; Fig. 3C). 
3.4 Oesophageal pressure and diaphragm and EIC EMGs during airway obstruction in anaesthetized 
mice 
Representative original recordings of oesophageal pressure, diaphragm and EIC EMG activities 
during baseline conditions (FiO2 = 0.60) and peak sustained inspiratory efforts during protracted 
airway obstruction are shown in Figure 4A and 4B. Obstruction significantly increased sub-
atmospheric pressure generation in wild-type (P < 0.0001; repeated measures two-way ANOVA with 
Bonferroni; Fig. 5A) and mdx mice (P < 0.0001; Fig. 5A), with no significant difference between the 
two groups (P = 0.1931 (gene); repeated measures two-way ANOVA; Fig. 5A). Diaphragm EMG 
activity was significantly increased during airway obstruction compared with baseline in wild-type (P 
< 0.0001; repeated measures two-way ANOVA with Bonferroni; Fig. 5B) and mdx mice (P < 0.001). 
However, diaphragm EMG activity was lower in mdx (P = 0.0479 (gene); repeated measures two-way 
ANOVA; Fig. 5B) and mdx mice had significantly lower diaphragm EMG activity compared with wild-
type during airway obstruction (P < 0.05; repeated measures two-way ANOVA with Bonferroni; Fig. 
5B). Airway obstruction significantly increased EIC EMG activity in wild-type (P < 0.0001; repeated 
measures two-way ANOVA with Bonferroni; Fig. 5C), but not mdx mice (P > 0.05). EIC EMG activity 
was lower in mdx compared with wild-type (P = 0.0003 (gene); repeated measures two-way ANOVA; 
Fig. 5C). Post hoc analysis revealed that EIC EMG activity was significantly lower during airway 
obstruction in mdx compared with wild-type mice (P < 0.0001; repeated measures two-way ANOVA 
with Bonferroni; Fig. 5C). In the light of these findings, we extended our analyses to determine 
inspiratory duration and respiratory EMG activities expressed as area under the curve (AUC) of the 
integrated EMG signals before and during airway obstruction (Table 3). During baseline recordings, 
inspiratory duration was shorter in mdx compared with wild-type mice (P < 0.05; repeated measures 
two-way ANOVA with Bonferroni).  Inspiratory duration was significantly longer during obstructed 
airway efforts, both in wild-type and mdx mice, with no genotype difference. Consistent with data 
for respiratory EMG amplitude during airway obstruction, both diaphragm (P < 0.05) and EIC (P < 
0.001) EMG AUC activities were significantly lower in mdx compared with wild-type mice (Table 3).   
3.5 Tracheal airflow and diaphragm and EIC EMG activity in anaesthetized, vagotomized mice 
Table 4 shows respiratory data in anaesthetized, vagotomized wild-type and mdx mice during 
baseline conditions (FiO2 = 0.60). There was no significant difference in fR, VT or VE between wild-type 
and mdx mice. Similarly, peak inspiratory and expiratory flows, and ETCO2 and SpO2 were equivalent 
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between groups. Figure 6A shows representative original recordings of tracheal airflow, diaphragm 
and EIC EMG activities in anaesthetized, vagotomized mice during baseline conditions (FiO2 = 0.60). 
Peak respiratory efforts during chemoactivation increased VT (P < 0.0001 (peak breath); repeated 
measures two-way ANOVA; Fig. 6B), peak inspiratory flow (P = 0.027; Fig. 6C) and peak expiratory 
flow (P = 0.016; Fig. 6D), with no difference between wild-type and mdx mice. Diaphragm EMG 
activity increased during peak respiratory efforts (P = 0.0128 (peak breath); repeated measures two-
way ANOVA; Fig. 6E) in wild-type and mdx mice, with equivalent diaphragm EMG activity between 
groups (P = 0.4055 (gene); repeated measures two-way ANOVA; Fig. 6E). Diaphragm EMG 
recruitment (delta EMG amplitude) during peak respiratory efforts compared with baseline was 
equivalent between wild-type and mdx (P = 0.9953; unpaired Student’s t test; Fig. 6F). EIC EMG 
activity was significantly lower during baseline conditions in mdx mice compared with wild-type (P < 
0.05; repeated measures two-way ANOVA with Bonferroni; Fig. 6G) and during peak 
chemoactivation (P < 0.01). EIC EMG recruitment (delta EMG amplitude) during peak ventilation 
compared with baseline was significantly lower in mdx compared with wild-type mice (P = 0.0434; 
unpaired Student’s t test; Fig. 6H). 
4. Discussion 
The main findings of the study are: (i) there is substantial diaphragm muscle weakness in young adult 
mdx mice; (ii) ventilatory capacity in response to maximum chemostimulation is equivalent between 
conscious wild-type and mdx mice; (iii) peak tidal volume and peak inspiratory and expiratory flows 
during maximum chemoactivation are equivalent in anaesthetized, vagotomized wild-type and mdx 
mice; (iv) peak inspiratory pressure-generating capacity is preserved in mdx mice during ventilatory 
(chemoactivated breathing and augmented breaths) and non-ventilatory (sustained tracheal 
occlusion) behaviours; (v) diaphragm and EIC EMG activities are lower during airway obstruction in 
mdx compared with wild-type mice. 
Our study confirmed substantial diaphragm muscle weakness in young adult mdx mice, consistent 
with our recent reports (Burns et al., 2017a,c). Diaphragm deficits in mdx mice were evidenced by 
significantly reduced twitch and tetanic isometric force compared with wild-type. The force-
frequency relationship revealed considerable force loss in the frequency range of 60-160 Hz, 
corresponding to a broad range of ventilatory and non-ventilatory behaviours (Sieck et al., 2013; 
Mantilla et al., 2014). We have previously documented considerable muscle fibre damage and 
remodelling in dystrophic diaphragm at this age, with increased variability of muscle fibre size, 
centralized myonuclei, altered myosin heavy chain isoform composition, and collagen deposition 
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(Burns et al., 2017c, 2018). Force loss was accompanied by decreases in muscle shortening and 
velocity of shortening. 
Notwithstanding the profound diaphragm weakness in mdx, we reasoned that ventilatory 
behaviours might be protected owing to the large reserve capacity of the diaphragm muscle, such 
that maximum ventilation during chemoactivation can be achieved with <40% of peak diaphragm 
force (Sieck & Fournier, 1989; Mantilla et al., 2010; Medina-Martínez et al., 2015; Greising et al., 
2016). In contrast, we hypothesize that non-ventilatory behaviours such as airway obstruction, 
airway clearance, respiratory reflexes encompassing coughing and sneezing, requiring substantially 
elevated respiratory muscle activation, critical for the safeguarding of pulmonary function are 
compromised in dystrophic disease. Dysphagia and poor airway control increase the risk of 
obstructive airway events during sleep, which are common in teenage DMD boys (Barbé et al., 1994; 
Khan & Heckmatt, 1994; Suresh et al., 2005; Sawnani et al., 2015).  Peak respiratory pressures are 
low in DMD and are known to decline progressively with advancing disease (Khirani et al., 2014). 
We assessed ventilation in response to hypercapnic, and hypercapnic hypoxic challenges, which 
confirmed the capacity for mdx mice to enhance ventilation. Ventilation during graded hypercapnia 
was equivalent in mdx and wild-type mice, revealing that CO2 chemosensitivity is intact in young 
adult mdx mice, which retain considerable ventilatory reserve and, despite diaphragm dysfunction, 
maintain a capacity to elevate VE to wild-type levels, through increases in rate and volume. This 
preserved capacity to elevate pulmonary ventilation was further revealed during exposure to 
hypercapnic hypoxia with peak ventilation increasing more than 3-fold in mdx mice, equivalent to 
responses in wild-type mice. We acknowledge the limitations of accurate determination of tidal 
volume by the method of plethysmography, which may have been further limited in our study owing 
to our estimation (not continuous measurement) of body temperature. 
In anaesthetized mice, we demonstrated that peak inspiratory oesophageal pressure generation was 
equivalent during basal breathing (FiO2 = 0.60) in mdx and wild-type mice. Acute chemoactivation 
(FiO2 = 0.15 & FiCO2 = 0.05) increased ventilatory drive and the magnitude of the enhanced peak 
inspiratory oesophageal pressure was equivalent in mdx and wild-type mice. This confirmed the lack 
of mechanical deficit in young adult mdx mice and hence no limitation in sub-atmospheric pressure-
generating capacity during chemoactivation. Diaphragm EMG responses to hypercapnic hypoxia 
were equivalent in mdx compared with wild-type mice.  As such, it is likely that even the 
compromised dystrophic mdx diaphragm is capable of supporting high ventilatory demand.  
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We extended this line of enquiry by way of assessment of spontaneous augmented breaths (sighs), 
which result in elevated diaphragm motor unit recruitment beyond that observed during 
chemoactivation (Mantilla et al., 2011; Seven et al., 2014), producing up to 50% of peak 
transdiaphragmatic pressure in mice (Greising et al., 2013; 2015; 2016). Interestingly, during 
augmented breaths, peak inspiratory oesophageal pressure generation was preserved and 
significantly greater in mdx compared with wild-type mice, again convincingly demonstrating a lack 
of mechanical constraint in 8-week-old mdx mice despite substantial diaphragm weakness 
(approaching 50% force loss compared with wild-type in the range 60-100Hz). Of note, diaphragm 
EMG recruitment during spontaneous augmented breaths was equivalent (not potentiated) in mdx 
compared with wild-type mice. Thus, as is the case for ventilation during chemoactivation, 
augmented breaths are not compromised in young adult mdx mice, insofar as enhanced inspiratory 
pressures can be achieved even with 50% reduction in force-generating capacity of the diaphragm, 
presumably because such efforts either remain within the reserve capacity of the dystrophic 
diaphragm, or they are facilitated by accessory muscle recruitment, which can compensate for 
efforts exceeding the reserve capacity of the weakened mdx diaphragm. Of note in our study, 
inspiratory pressure generation during augmented breaths was greater in mdx compared with wild-
type mice, but diaphragm EMG recruitment was equivalent between groups. 
In addition, we examined tracheal airflow in anaesthetized, vagotomized mice during 
chemoactivation, wherein we characterized maximum ventilatory effort, exceeding that of volume-
related measures in conscious mice owing to the release of vagal inhibition of breathing with 
superimposed chemoactivation of respiratory motor outflow. Direct measures of peak VT and peak 
inspiratory and expiratory flows were equivalent in vagotomized wild-type and mdx mice, confirming 
and extending observations from our studies using plethysmography. Peak diaphragm EMG activity 
was equivalent in wild-type and mdx mice, whereas EIC EMG was significantly lower in mdx mice. 
Preserved neural drive to the weakened mdx diaphragm may be wholly adequate to generate even 
the large volumes and respiratory flows observed in vagotomized mdx mice. In this respect, our 
findings are consistent with a variety of other studies revealing that transdiaphragmatic pressure-
generating capacity during high ventilatory demand (chemoactivation; augmented breaths) is within 
50% of maximum capacity (Sieck & Fournier, 1989; Mantilla et al., 2010), including studies in mice 
(Greising et al., 2013, 2015, 2016), and these behaviours can be adequately met even in the context 
of motor neuron loss (Khurram et al., 2018a) or age-related sarcopenia of the diaphragm (Khurram 
et al., 2018b). Although force loss is severe in mdx diaphragm, ventilatory behaviours are 
accommodated, at least early in dystrophic disease. 
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Our consideration of respiratory-related capacity to this point was limited to peak ventilation during 
chemoactivation of breathing, albeit including observations in animals with removal of vagal afferent 
inhibition of respiratory drive. We reasoned that the preserved capacity in mdx might be limited to 
the ventilatory range, such that mechanical deficit might be revealed during non-ventilatory efforts, 
particularly over sustained periods, which evoke near-maximum respiratory system activation, or at 
least activation well beyond the reserve capacity of the weakened mdx diaphragm. To investigate 
this, we extended our studies to examine peak inspiratory pressure-generating capacity in wild-type 
and mdx mice during protracted sustained tracheal occlusion, which results in greater motor 
recruitment of respiratory muscles beyond that of augmented breaths (Mantilla et al., 2011; 
Greising et al., 2013; Seven et al., 2014). Previously it has been shown that sustained tracheal 
occlusions lasting 15s in anaesthetized mice result in the generation of transdiaphragmatic pressures 
~65-82% of peak pressures evoked by bilateral phrenic nerve stimulation (Greising et al., 2013, 2015, 
2016), with transdiaphragmatic pressure values of ~72cmH20 during obstruction in young male mice, 
equating to ~78% of maximum transdiaphragmatic pressure (Greising et al., 2015). In our study, 
oesophageal pressure recordings were performed in anaesthetized mice with contemporaneous 
measurement of diaphragm and EIC EMG activity. Tracheal occlusions sustained for 30-40s 
generated impressive sub-atmospheric inspiratory pressures in wild-type and mdx mice. The 
sustained efforts during the final phase of airway obstruction were likely reflective of maximum or 
near-maximum respiratory system performance, evidenced by progressively greater sub-
atmospheric inspiratory pressures during occlusion to a sustained nadir associated with maximal 
diaphragm and EIC recruitment. Indeed, sub-atmospheric pressures were often noted to decrease 
further (become more ‘negative’) both in wild-type and mdx mice, when diaphragm EMG activity 
reached a maximum plateau or even decreased compared with preceding efforts. 
Tracheal occlusion in our study resulted in sub-atmospheric pressure generation that clearly 
exceeded the reserve capacity of the dystrophic diaphragm. Moreover, both diaphragm and EIC 
EMG activities (determined both as amplitude and AUC of the integrated EMG signals) were 
substantially lower during peak sustained efforts in mdx compared with wild-type mice, with a 
relatively greater reduction of activity in EIC EMG compared with diaphragm EMG in mdx mice. 
Decreased EMG activity during airway obstruction could reflect impaired motor control of the 
diaphragm and EIC muscles, but is more likely fully explained by impaired neuromuscular 
transmission given the evidence in young mdx mice of increased variability of neural transmission to 
the diaphragm (Personius & Sawyer, 2006) and decreased amplitude of mdx diaphragm motor end 
plate potentials (Carlson & Roshek, 2001). Neuromuscular impairment during high demand 
behaviours that exceed the reduced reserve capacity of the mdx diaphragm would be expected to 
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translate to substantial inability to generate peak inspiratory pressures equivalent to wild-type, 
beyond that predicted by assessment of diaphragm peak force. However, in our study, peak 
sustained inspiratory pressures during airway obstruction were equivalent in wild-type and mdx 
mice. We determined that inspiratory duration, which is prolonged during obstructed efforts, was 
equivalent during peak sustained efforts in wild-type and mdx mice, highlighting that compensation 
in the capacity to generate equivalent sub-atmospheric pressures in mdx mice does not depend 
upon altered control of inspiratory timing. We therefore reason that recruitment of support muscles 
beyond the primary muscles of inspiration (diaphragm and EIC) contributes substantively to non-
ventilatory pressure-generating capacity in young dystrophic mdx mice, owing to necessary and 
sufficient compensation that is capable of facilitating increased thoracic volume. It is clear from our 
study that T3 EIC muscle activity is severely curtailed in mdx mice, suggesting that intercostal 
muscles do not provide compensation during high demand behaviours in mdx mice. Of note, 
ventilatory capacity is maintained in rat models of amyotrophic lateral sclerosis (ALS) at end-stage 
disease despite substantial loss of phrenic motor neurons (Nichols et al., 2013; Nichols et al., 2014). 
Indeed, it is established that scalene and trapezius muscles enhance ventilation in ALS mice (Romer 
et al. 2017).  
Elegant work in dystrophic dogs with the GRMD mutation showed a reduced diaphragm contribution 
to inspiratory tidal volume during wakefulness at rest in the lateral recumbent position (Mead et al. 
2014). Moreover, there was loss of ventilatory capacity during pharmacological stimulation of 
breathing, but capacity is partly compensated for by expiratory muscles that serve to lower end-
expiratory chest wall volume. The authors offer an excellent perspective on a proposed 
redistribution of the work of breathing beyond the diaphragm to accessory and auxiliary muscles in 
the context of dystrophic disease. Of further interest, a strong argument is also presented by Mead 
and colleagues (2014) in favour of viewing increased diaphragm stiffness as an adaptive benefit in 
muscular dystrophy (Mead et al. 2014), an outcome that may defend against cranial movement of 
the diaphragm during subatmospheric pressure generation by accessory and support muscles, 
particularly during high demand behaviours. Similar changes in the two-compartment chest wall 
model of breathing are reported in DMD patients (LoMauro et al. 2010), with outcomes dependent 
upon posture (lower diaphragm contribution to tidal volume in the supine position), but surprisingly 
not influenced by the presence or absence of scoliosis (LoMauro et al., 2010). It is plausible that 
expiratory muscle activation is increased in dystrophic disease in support of ventilatory capacity. 
Beyond the recognised contribution of active expiration to increased ventilatory capacity in support 
of inspiratory muscle work, expiratory muscle recruitment could serve to shorten expiratory 
duration and decrease end-expiratory lung volume, accessing expiratory reserve volume in 
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dystrophic animals and DMD boys allowing increases in tidal volume (Mead et al. 2014), until 
compensation is progressively lost with advancing disease. 
In respect of the preserved capacity of mdx mice to generate peak inspiratory pressures during 
airway obstruction, we posit that auxiliary muscle recruitment in support of peak pressure-
generating capacity offers the most plausible explanation for respiratory compensation in young 
mdx mice, notwithstanding that the muscle group(s) pivotal to the support of respiratory system 
compensation during non-ventilatory behaviours were not identified in the present study. Fibrosis in 
mdx (and DMD) leads to decreased chest wall compliance and increased work of breathing. Whereas 
the extent of fibrosis and its expected impact on chest wall compliance was not determined in the 
present study, and may not be a major pathology in young mdx mice, but with presumed greater 
relevance at later stages of disease, we reason that compensated inspiratory pressure-generating 
capacity in mdx mice does not relate to increased chest wall compliance. Indeed, compensation is 
likely limited by increased chest wall stiffness during progressive disease in mdx and DMD, adding 
further to the burden of a redistributed workload on accessory and auxiliary muscles.  
The long-term compensatory capacity of primary and secondary respiratory motor pathways and 
muscles in mdx (and DMD) is not known. We speculate that in dystrophic disease there may be serial 
recruitment of accessory and other support muscles that facilitate respiratory performance, but in 
turn show progressive deterioration. Mechanical strain leads to injury in dystrophic muscle, 
triggering a spiral of progressive dysfunction. It is known, for example, that recruitment of the mdx 
diaphragm in exercise expedites diaphragm dysfunction (Capogrosso et al., 2017). As such, the early 
modest decline in inspiratory pressure-generating capacity in mdx mice that we observed in our 
study (~10% loss comparing median values in Fig. 5A), could conceivably decline further with 
advancing disease. We suggest that compensation does not prevail during progressive dystrophic 
disease, a hypothesis previously suggested by others (Gayraud et al., 2007). It is especially 
interesting to consider that peak hypercapnic ventilation is normal in 5-month old mdx mice 
(Gayraud et al., 2007), but decreased at 7-months, 10-12 months (Gosselin et al., 2003) and 16 
months of age (Gayraud et al., 2007). Interestingly, diaphragm dysfunction presents early in the mdx 
model, with relatively modest further deterioration in force-generating capacity with advancing 
disease (eg 50-66% force loss at 7-14 months of age: (Lynch et al., 2001; Gosselin et al., 2003; Selsby 
et al., 2016). We therefore suggest that progressive decline in ventilatory performance in mdx (and 
perhaps DMD) potentially relates to an increased dependence upon, and progressive loss of 
compensatory mechanisms, which combined with diaphragm dysfunction underpins the 
development of respiratory morbidity. In DMD, there is a progressive decline in pulmonary function 
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and respiratory muscle strength culminating in reduced ventilation (Smith et al., 1989; De Bruin et 
al., 1997; Hukins & Hillman, 2000; Khirani et al., 2014). The decline in peak respiratory pressure 
generation in DMD has important prognostic value (Phillips et al., 2001; Khirani et al., 2014). 
In summary, our study highlights new facets to breathing with neuromuscular disease. We 
demonstrate profound diaphragm muscle weakness during early disease progression in young adult 
mdx mice, but a capacity to preserve ventilatory behaviours over a wide range. Ventilatory demand 
is likely adequately met by even the compromised dystrophic diaphragm, at least in early disease. 
We reveal the remarkable preservation of inspiratory pressure-generating capacity during sustained 
airway obstruction in mdx mice, which illustrates necessary and sufficient compensation within the 
respiratory control system. We hypothesize that there is an increased reliance on compensatory 
support, which is progressively lost in mdx (and DMD), which combined with devastating primary 
respiratory muscle (and neuromuscular junction) dysfunction contributes to respiratory-related 
morbidity culminating in the sequential loss of non-ventilatory and ventilatory capacity, ultimately 
leading to respiratory morbidity and failure in advanced disease. Our findings have relevance to 
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Translational perspective 
Duchenne muscular dystrophy (DMD) is an X-linked fatal neuromuscular disease. Respiratory-related 
morbidity and mortality are widely recognized features of DMD, yet there is a considerable 
knowledge gap in respect of a comprehensive understanding of the neural control of breathing and 
respiratory-related behaviours in the human dystrophinopathies. The dystrophin-deficient mdx 
mouse is a widely used pre-clinical model of DMD. In young adult mdx mice, we examined 
inspiratory pressure-generating capacity across a range of ventilatory and non-ventilatory 
behaviours to explore inherent deficits and compensations that manifest in dystrophic disease. Our 
study reveals remarkable compensation in support of respiratory system performance, at least early 
in disease, despite evidence of profound diaphragm muscle weakness. Our data illustrate a capacity 
to preserve peak inspiratory pressure generation, despite respiratory muscle weakness and impaired 
neural recruitment of primary inspiratory muscles (diaphragm and intercostal muscles). Our findings 
point to a considerable reserve in the capacity of the respiratory system to perform a broad range of 
function, probably owing to recruitment of auxiliary muscles in support of peak respiratory-related 
performance. Peak inspiratory pressure generation is most relevant to protective reflexes related to 
airway maintenance and clearance, which is particularly relevant to neuromuscular (and 
neurodegenerative) conditions, given that dysphagic patients are at risk of obstructive airway events 
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during sleep, and aspiration pneumonia. It will be important to determine if similar compensation 
presents in DMD boys and if the progressive loss of respiratory performance with advancing disease 
relates to a decline or loss of compensatory mechanisms. Clinical assessment of auxiliary muscle 
control of breathing during maximal pressure-generating manoeuvres is clearly warranted (e.g. 
assessment of scalene, sternocleidomastoid and trapezius EMG activities and oesophageal pressure 
measurement during maximal sniff manoeuvres). Rehabilitative strategies focussed on auxiliary 
muscles that support inspiratory pressure generation may prove promising. Further delineation of 
the compensatory signature of the neuromuscular control system governing respiratory 
performance in animal models of DMD may provide insight into mechanisms that can be protected 
and/or further harnessed in the development of therapeutic strategies for DMD.  
Table legends 
Table 1. Ex vivo wild-type and mdx diaphragm muscle contractile kinetics 
Definition of abbreviations: CT, contraction time; ½ RT, half-relaxation time; Smax, peak shortening; 
Vmax, peak shortening velocity; Lo, optimum length. Data are shown as mean ± SD and were 
statistically compared using two-tailed unpaired Student’s t tests. 
Table 2. Baseline respiratory parameters in anaesthetised wild-type and mdx mice 
Definition of abbreviations: fR, respiratory frequency; SpO2, peripheral capillary oxygen saturation; 
ETCO2, end-tidal carbon dioxide. Data are shown as mean ± SD and were statistically compared using 
two-tailed unpaired Student’s t tests. 
Table 3. Baseline respiratory parameters in anaesthetized wild-type and mdx mice before and 
during peak sustained efforts during airway occlusion 
Definition of abbreviations: fR, respiratory frequency; SpO2, peripheral capillary oxygen saturation; Ti, 
inspiratory duration; TTP, time to peak sub-atmospheric pressure; Dia AUC, area under the curve of 
diaphragm integrated EMG signal (A.U. = arbitrary units); T3 EIC AUC, area under the curve of T3 
external intercostal integrated EMG signal (A.U. = arbitrary units). Data are shown as mean ± SD and 
were statistically compared by repeated measures two-way analysis of variance (RMANOVA). * P < 
0.05 compared with wild-type baseline; $ P < 0.05, $$$ P < 0.001 compared with wild-type 
obstruction. 
Table 4. Baseline respiratory parameters in anaesthetized, vagotomized wild-type and mdx mice 
Definition of abbreviations: fR, respiratory frequency; VT, tidal volume; VE, minute ventilation; PIF, 
peak inspiratory flow; PEF, peak expiratory flow; ETCO2, end-tidal carbon dioxide; SpO2, peripheral 
capillary oxygen saturation. Data are shown as mean ± SD and were statistically compared using 
two-tailed unpaired Student’s t tests. 
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Figure legends 
Figure 1. Ex vivo wild type and mdx diaphragm muscle contractile function 
A, B, C, and D, original traces of ex vivo diaphragm muscle twitch contraction (A), tetanic contraction 
(B), force-frequency relationship (C) and maximum unloaded shortening (D) for wild-type (WT; black) 
and mdx (grey) preparations. E, group data for diaphragm muscle twitch (Pt) and tetanic (Po) force in 
WT (n = 8) and mdx (n = 9) mice. Tetanic force was measured following stimulation at 100 Hz ex vivo. 
Values are expressed as box and whisker plots (median, 25-75 percentile and scatter plot). Data 
were statistically compared by unpaired Student’s t tests. *P < 0.05, ***P < 0.001 compared with 
corresponding WT value. F, group data (mean ± SD) for diaphragm muscle force-frequency 
relationship ex vivo in WT (open) and mdx (grey) preparations. Data were statistically compared by 
repeated measures two-way ANOVA (frequency x gene) followed by Bonferroni post hoc test. **P < 
0.01, ***P < 0.001 compared with corresponding WT value.  
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Figure 2. Ventilation in response to chemostimulation in conscious wild-type and mdx mice 
A, representative respiratory flow traces during normoxia (21% O2) and hypercapnic hypoxia (10% O2 
/ 6% CO2) in a wild-type (WT; black;) and mdx (grey) mouse; inspiration downwards. B, C, D and E, 
group data for respiratory frequency (B), tidal volume (C), minute ventilation (D) and mean 
inspiratory flow (E; VT/Ti) during graded hypercapnia (2, 4 and 6% CO2) and hypercapnic hypoxia 
(10% O2 / 6% CO2). Values are expressed as box and whisker plots (median, 25-75 percentile and 
scatter plot). Data were statistically compared by repeated measures two-way ANOVA.  
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Figure 3. Oesophageal pressure and diaphragm EMG activity during ventilatory behaviours in 
anaesthetized wild-type and mdx mice 
A, representative traces of oesophageal pressure and diaphragm (Dia) muscle raw and integrated 
(Int.) electromyogram (EMG) activity in a wild-type (WT; black) and mdx (grey) mouse during 
baseline (60% inspired O2) and during an augmented breath (shaded). B and C, group data for 
oesophageal pressure (B) and diaphragm integrated EMG activity (C) during baseline, 
chemostimulation (15% O2 / 5% CO2) and augmented breaths for WT (n = 7-9) and mdx (n = 6-9) 
mice. Values are expressed as box and whisker plots (median, 25-75 percentile and scatter plot). 
Data were statistically compared by two-tailed unpaired Student’s t tests. *P = 0.025, **P = 0.0013 
compared with corresponding WT values. 
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Figure 4. Oesophageal pressure and diaphragm and EIC EMG activities in anaesthetized wild-type 
and mdx mice: Original recordings 
A, representative recordings of oesophageal pressure and diaphragm (Dia) and T3 external 
intercostal (T3 EIC) raw and integrated (Int.) electromyogram (EMG) activity in a wild-type (WT; 
black) and mdx (grey) mouse during baseline (FiO2 = 0.60) and protracted tracheal occlusion (~30-40 
seconds). B, representative traces of oesophageal pressure and Dia and T3 EIC raw and Int. EMG 
activity in a WT and mdx mouse during baseline and peak inspiratory efforts (shaded) during a 
protracted tracheal occlusion.  
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Figure 5. Oesophageal pressure and diaphragm and EIC EMG activities during tracheal occlusion in 
anaesthetized wild-type and mdx mice: Group data 
A-C, group data for oesophageal pressure (A), diaphragm EMG activity (B) and T3 external intercostal 
(T3 EIC) EMG activity (C) during baseline conditions and during tracheal occlusion (average of 5 
successive peak breaths) in WT (n=10) and mdx (n=10) mice. Values are expressed as box and 
whisker plots (median, 25-75 percentile and scatter plot). Data were statistically compared by 
repeated measures two-way ANOVA with Bonferroni post hoc test. *P < 0.05; ****P < 0.0001 
compared with corresponding WT values. 
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Figure 6. Tracheal airflow and diaphragm and EIC EMG activities in anaesthetized, vagotomized 
wild-type and mdx mice 
A, representative recordings of tracheal airflow, tidal volume, raw and integrated (Int.) diaphragm 
(Dia) and T3 external intercostal (T3 EIC) electromyogram (EMG) activities for an anaesthetized wild-
type (WT) mouse (black) and mdx mouse (grey) during baseline conditions (FiO2 = 0.60). B, C and D, 
group data for tidal volume (B), peak inspiratory flow (C) and peak expiratory flow (D) during 
baseline conditions and during spontaneous peak breaths during chemoactivation (FiO2 = 0.15 / 
FiCO2 = 0.06). E, diaphragm EMG activity during baseline and peak breaths. F, diaphragm EMG 
response (expressed as absolute change from baseline amplitude) during peak breaths. G, EIC EMG 
activity during baseline and peak breaths. H, EIC EMG activity (expressed as absolute change from 
baseline amplitude) during peak breaths. Values are expressed as box and whisker plots (median, 25-
75 percentile and scatter plot). Data were statistically compared by repeated measures two-way 
ANOVA or two-tailed unpaired Student’s t tests. *P < 0.05; **P < 0.01 compared with corresponding 
WT values.  
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P (Student’s t test) 
CT (ms) 17.3 ± 2.3 20.3 ± 2.6 0.0270 
½ RT (ms) 19.6 ± 6.9 23.2 ± 4.3 0.2177 
Smax (cm) 0.36 ± 0.07 0.26 ± 0.1 0.0386 
Smax (L Lo
-1) 0.36 ± 0.07 0.30 ± 0.13 0.3252 
Vmax (cm s
-1) 4.1 ± 1.1 2.8 ± 1.3 0.0420 
Vmax (Lo s
-1) 4.1 ± 1.1 3.3 ± 1.9 0.3373 
Lo (cm) 1.0 ± 0.1 0.9 ± 0.2 0.1024 
 
Table 2.  
 
 Wild-type 
(n = 9) 
mdx 
(n = 9) 
P (Student’s t test) 
fR (breaths min
-1) 195 ± 11 230 ± 11 < 0.0001 
SpO2 (%) 97.2 ± 1.9 96.5 ± 2.0 0.4069 
ETCO2 (mmHg) 32.9 ± 3.3 30.3 ± 3.0 0.0966 
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P (RM two-way ANOVA) 
 Baseline Obstruction Baseline Obstruction  
fR (breaths 
min-1) 
217 ± 34 76 ± 18 227 ± 41 109 ± 32 Obstruction: P < 0.0001; Gene: P = 0.0802; 
Obstruction x Gene: P = 0.1962 
SpO2 (%) 95.1 ± 2.1 40.1 ± 9.5 95.8 ± 1.9 
 
46.3 ± 9.1 Obstruction: P < 0.0001; Gene: P = 0.116;  
Obstruction x Gene: P = 0.2132 
Ti (ms) 105 ± 15 144 ± 18 88 ± 14* 
 
135 ± 15 Obstruction: P < 0.0001; Gene: P = 0.0441; 
Obstruction x Gene: P = 0.2073 
TTP (ms) 58 ± 15 76 ± 11 50 ± 10 
 
82 ± 13 Obstruction: P < 0.0001; Gene: P = 0.7911;  
Obstruction x Gene: P = 0.0438 
Dia AUC (A.U.) 101 ± 76 585 ± 241 57 ± 56 
 
382 ± 242$ Obstruction: P < 0.0001; Gene: P = 0.0582; 
Obstruction x Gene: P = 0.1349 
T3 EIC AUC 
(A.U.) 
65 ± 28 594 ± 215 34 ± 24 198 ± 131$$$ Obstruction: P < 0.0001; Gene: P < 0.0001; 
Obstruction x Gene: P = 0.0001 
      






P (Student’s t test) 
fR (breaths min
-1) 64 ± 19 60 ± 14 0.6932 
VT (ml g
-1) 0.032 ± 0.005 0.032 ± 0.003 0.9800 
VE (ml g
-1 min-1) 2.0 ± 0.7 1.9 ± 0.4 0.6343 
PIF (ml g-1 s-1) 1.03 ± 0.16 1.15 ± 0.13 0.1345 
PEF (ml g-1 s-1) 1.04 ± 0.18 1.08 ± 0.29 0.7207 
ETCO2 (mmHg) 53.2 ± 3.7 50.5 ± 6.1 0.2735 
SpO2 (%) 94.8 ± 2.5 94.1 ± 3.1 0.5821 
Body mass (g) 24.8 ± 1.5 26.1 ± 0.8 0.0382 
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